Nasdaq

Castle Biosciences Presents Data on Its Inflammatory Skin Disease Pipeline Test at the 4th Annual Revolutionizing Atopic Dermatitis (RAD) Conference

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced a recent poster presentation ...
Nasdaq

Early Discovery Data Shows Ability of Castle Biosciences’ Pipeline Program to Distinguish Between Responders and Non-Responders to an Atopic Dermatitis Therapy

Castle’s innovative pipeline initiative to develop a genomic test aimed at guiding systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions ...
dbta

Building Modern Data Pipelines Using dbt—Tips and Tricks

Earlier this year, I had the privilege of serving on the organizing committee for the DataTune conference in my hometown of Nashville, Tenn. Unlike many database-specific or platform-specific ...
InfoQ

Effective Test Automation Approaches for Modern CI/CD Pipelines

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...
TechRepublic

A guide to effective data migration testing

Data migration testing ensures that all your data sets and system integrity are maintained when they’re transferred to a different host. Depending on the size of your organization and the work it does ...
Business Wire

Early Discovery Data Shows Ability of Castle Biosciences’ Pipeline Program to Distinguish Between Responders and Non-Responders to an Atopic Dermatitis Therapy

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data showing the ability ...